Timothy Hoey, Chief Scientific Officer at Tenaya Therapeutics, Inc. (TNYA), sold 1,353 shares at $10.13 ($14K) on 2022-04-26, disclosed to the SEC on 2022-04-28.
Scheduled sale ($14k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TNYA | SELL | 2024-02-16 | $27K | — | Filing → |
| TNYA | SELL | 2023-08-29 | $31K | — | Filing → |
| TNYA | SELL | 2023-08-18 | $15K | — | Filing → |